HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L D Lewis Selected Research

antibody MDXH447

10/2003Taxanes synergize with the bispecific antibody MDXH447 to enhance antibody-dependent cell-mediated cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L D Lewis Research Topics

Disease

10Neoplasms (Cancer)
08/2017 - 02/2001
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2007 - 08/2001
2Adenocarcinoma
08/2001 - 02/2001
1Breast Neoplasms (Breast Cancer)
12/2007
1Leukemia
12/2007
1Lymphoma (Lymphomas)
12/2007
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2007
1Hematologic Neoplasms (Hematological Malignancy)
12/2007
1Necrosis
01/2007
1Poisoning
01/2007
1Hypokinesia (Bradykinesia)
01/2007
1Parkinsonian Disorders (Parkinsonism)
01/2007
1Muscle Rigidity
01/2007
1Hypersensitivity (Allergy)
11/2006
1Mitochondrial Diseases (Mitochondrial Disease)
04/2004
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2003
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2003
1Ventricular Tachycardia
04/2001
1Prostatic Neoplasms (Prostate Cancer)
01/2001

Drug/Important Bio-Agent (IBA)

3Docetaxel (Taxotere)FDA Link
06/2014 - 10/2003
2Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2014 - 11/2006
2Mitochondrial DNA (mtDNA)IBA
12/2007 - 04/2004
2GemcitabineFDA Link
12/2007 - 08/2001
2Interferon-gamma (Interferon, gamma)IBA
10/2003 - 02/2001
2MDX-H210 antibodyIBA
02/2001 - 02/2001
1trebananibIBA
08/2017
1Cytochrome P-450 CYP2C19IBA
11/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2010
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
11/2010
1pazopanibFDA Link
11/2010
1Cytochrome P-450 CYP3AIBA
11/2010
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
11/2010
1Tyrosine Kinase InhibitorsIBA
11/2010
1Cytochrome P-450 CYP2C9IBA
11/2010
1Topotecan (Hycamtin)FDA LinkGeneric
03/2009
1pyrimidineIBA
12/2007
1plitidepsin (aplidine)IBA
12/2007
1Adenosine Triphosphate (ATP)IBA
12/2007
1Antineoplastic Agents (Antineoplastics)IBA
12/2007
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2007
1Pharmaceutical PreparationsIBA
12/2007
1NucleosidesIBA
12/2007
1OxalatesIBA
01/2007
1levodopa drug combination carbidopa (Nakom)FDA LinkGeneric
01/2007
1Ethylene Glycol (Monoethylene Glycol)IBA
01/2007
1Methanol (Carbinol)IBA
01/2007
1antibody MDXH447IBA
10/2003
1Taxoids (Taxanes)IBA
10/2003
1Epidermal Growth Factor (EGF)IBA
10/2003
1Paclitaxel (Taxol)FDA LinkGeneric
10/2003
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2003
1UbiquinoneIBA
01/2003
1Quetiapine Fumarate (Seroquel)FDA Link
04/2001
1EnzymesIBA
02/2001
1Immunoglobulin G (IgG)IBA
02/2001
1CytokinesIBA
02/2001
1Superoxides (Superoxide)IBA
02/2001
1Fc Receptors (Fc Receptor)IBA
02/2001
1Biological ProductsIBA
01/2001
1LigandsIBA
01/2001
1IgG Receptors (Fc gamma RI)IBA
01/2001

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2014 - 07/2006
1Premedication
11/2006
1Radiotherapy
08/2001